XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Investment - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)     116,768       116,768  
Beginning balance $ 1,510,441 $ 1,429,994 $ 1,418,697 $ 1,388,107 $ 1,381,388 $ 1,353,422 $ 1,418,697 $ 1,353,422
Net income 97,229 126,251 92,904 81,949 97,316 114,891 $ 316,384 294,156
Foreign currency adjustments 29,494 (1,313) (19,490) (14,891) (6,536) 2,477    
Dividends declared (75,896) (74,006) (74,065) (73,724) (73,577) (73,581)    
Stock issued for employee benefit plans 56,794 9,943 (10,725) 7,476 15,206 (375)    
Stock-based compensation expense $ 22,004 19,572 22,673 15,667 6,035 15,607    
Repurchase of common stock         (31,725) (31,053)    
Ending balance (in shares) 118,083           118,083  
Ending balance $ 1,640,066 $ 1,510,441 $ 1,429,994 $ 1,404,584 $ 1,388,107 $ 1,381,388 $ 1,640,066 $ 1,404,584
Dividends declared, per share (in dollars per share) $ 0.62 $ 0.61 $ 0.61 $ 0.61 $ 0.61 $ 0.61    
Common Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares) 117,262 117,000 116,768 116,335 116,437 116,323 116,768 116,323
Beginning balance $ 11,726 $ 11,700 $ 11,677 $ 11,633 $ 11,644 $ 11,632 $ 11,677 $ 11,632
Stock issued for employee benefit plans (in shares) 821 262 232 130 228 430    
Stock issued for employee benefit plans $ 82 $ 26 $ 23 $ 14 $ 22 $ 44    
Stock-based compensation expense (in shares) 0 0 0 0 0 0    
Stock-based compensation expense $ 0 $ 0 $ 0 $ 0 $ 0 $ 0    
Repurchase of common stock (in shares)         (330) (316)    
Repurchase of common stock         $ (33) $ (32)    
Ending balance (in shares) 118,083 117,262 117,000 116,465 116,335 116,437 118,083 116,465
Ending balance $ 11,808 $ 11,726 $ 11,700 $ 11,647 $ 11,633 $ 11,644 $ 11,808 $ 11,647
Additional Paid-in Capital                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 756,135 746,998 754,093 734,244 730,363 743,288 754,093 743,288
Stock issued for employee benefit plans (6,654) (10,435) (29,768) (2,411) (2,154) (28,532)    
Stock-based compensation expense 22,004 19,572 22,673 15,667 6,035 15,607    
Ending balance 771,485 756,135 746,998 747,500 734,244 730,363 771,485 747,500
Retained Earnings                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 5,691,874 5,639,629 5,620,790 5,655,489 5,631,750 5,590,440 5,620,790 5,590,440
Net income 97,229 126,251 92,904 81,949 97,316 114,891    
Dividends declared (75,896) (74,006) (74,065) (73,724) (73,577) (73,581)    
Ending balance 5,713,207 5,691,874 5,639,629 5,663,714 5,655,489 5,631,750 5,713,207 5,663,714
Accumulated Other Comprehensive Loss                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (101,749) (100,436) (80,946) (92,919) (86,383) (88,860) (80,946) (88,860)
Foreign currency adjustments 29,494 (1,313) (19,490) (14,891) (6,536) 2,477    
Ending balance (72,255) (101,749) (100,436) (107,810) (92,919) (86,383) (72,255) (107,810)
Treasury Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (4,847,545) (4,867,897) (4,886,917) (4,920,340) (4,905,986) (4,903,078) (4,886,917) (4,903,078)
Stock issued for employee benefit plans 63,366 20,352 19,020 9,873 17,338 28,113    
Stock-based compensation expense 0 0 0 0 0 0    
Repurchase of common stock         (31,692) (31,021)    
Ending balance $ (4,784,179) $ (4,847,545) $ (4,867,897) $ (4,910,467) $ (4,920,340) $ (4,905,986) $ (4,784,179) $ (4,910,467)